Core Viewpoint - The board of directors of Kunshan Yaxiang Flavor Co., Ltd. has approved the first grant of the 2025 restricted stock incentive plan, ensuring compliance with relevant regulations and confirming the eligibility of the incentive recipients [1][2][3] Summary by Sections Public Disclosure and Verification - The company publicly disclosed the names and positions of the incentive recipients from August 27, 2025, to September 5, 2025, through its internal OA system, with no objections or negative feedback received during this period [1] Verification by the Compensation and Assessment Committee - The Compensation and Assessment Committee verified the list of incentive recipients, including their identification documents, employment contracts, and positions held within the company or its subsidiaries [2] - The committee confirmed that the recipients do not include foreign employees, shareholders holding more than 5% of the company, or immediate family members of the actual controller [2] Compliance with Regulations - The committee concluded that all recipients meet the qualifications set forth by the relevant laws, regulations, and normative documents, thus validating their eligibility for the incentive plan [3]

Core Viewpoint - The company has adjusted the grant price of its 2023 restricted stock incentive plan from 8.44 yuan per share to 8.14 yuan per share due to the implementation of the 2024 annual equity distribution [5][6][7]. Summary by Sections Adjustment of Grant Price - The adjustment of the grant price was approved during the 11th meeting of the third board of directors held on September 5, 2025 [1][2]. - The previous grant price was set at 8.44 yuan per share, which has now been adjusted to 8.14 yuan per share following the distribution of cash dividends [4][5]. Reasons for Adjustment - The adjustment was necessitated by the completion of the 2024 annual equity distribution, where the company distributed a cash dividend of 3.00 yuan per 10 shares, totaling 53,369,326.80 yuan (including tax) [5]. - The adjustment method follows the guidelines set forth in the company's incentive plan, which requires recalibration of the grant price in the event of dividend distributions [5]. Impact on the Company - The adjustment is in compliance with relevant laws and regulations and will not have a substantial impact on the company's financial status or operational results [6][7]. Opinions from Committees - The independent directors, compensation and assessment committee, and audit committee have all reviewed and agreed that the adjustment aligns with the company's incentive plan and regulatory requirements [6][7]. Legal Opinion - The legal counsel has confirmed that the adjustment has received the necessary authorizations and complies with applicable laws and regulations [7].

Core Points - The announcement details the achievement of vesting conditions for the first batch of the 2023 restricted stock incentive plan, including the number of eligible participants and shares to be vested [1][15][25] - The company has approved adjustments to the grant price of the restricted stock and the vesting conditions for both the first and second batches of the incentive plan [10][12][25] Summary by Sections Incentive Plan Overview - The total number of participants for the initial grant is 161, with 3 for the first batch of reserved grants and 6 for the second batch [1][10] - The total number of shares to be vested includes 1,009,740 shares for the initial grant and 72,000 shares for the first batch of reserved grants, with a vesting price of 8.14 yuan per share [1][15] Vesting Conditions - The vesting period for the initial grant is divided into three phases, with the second vesting period occurring 24 months after the grant date [2][3] - The vesting conditions require that the company does not have any negative audit opinions or fail to distribute profits as per regulations [4][19] Performance Targets - The performance assessment for the incentive plan spans three fiscal years (2023-2025), with specific net profit growth targets set for each year [6][20] - The targets include a net profit growth rate of 80% for 2023, 130% for 2024, and 215% for 2025, with corresponding trigger values [6][21] Individual Performance Assessment - Individual performance assessments will determine the actual number of shares vested, categorized into four levels (A, B, C, D) [7][22] - The actual vesting amount is calculated based on company performance and individual performance ratings [7][22] Approval Process - The company has followed the necessary approval procedures for the incentive plan, including independent opinions from the board and verification by the supervisory board [8][25] - Adjustments to the number of participants and shares due to resignations and performance results have been documented [10][12][25] Financial Impact - The vesting of shares will not significantly impact the company's financial structure or listing conditions, although it will affect earnings per share and return on equity [24][25] - The company will account for the stock options in accordance with relevant accounting standards, impacting costs and capital reserves [24]

Core Viewpoint - The company has successfully completed a share repurchase plan, acquiring a total of 1,439,317 shares, which represents 0.32% of its total share capital, with the repurchase aimed at employee stock ownership plans or equity incentives [1][3][5]. Summary by Sections Share Repurchase Plan - The share repurchase plan was first disclosed on November 15, 2024, with an implementation period from November 14, 2024, to November 13, 2025 [1]. - The expected repurchase amount is between 40 million yuan and 80 million yuan, with a maximum repurchase price of 47.00 yuan per share [1][2]. - The board approved the plan on November 14, 2024, allowing the use of self-owned funds and a special loan from a bank for the repurchase [1][2]. Implementation Status - The company began its share repurchase on November 26, 2024, using a centralized bidding method [2][3]. - As of the announcement date, the total repurchased shares amounted to 1,439,317, with a total expenditure of approximately 40.29 million yuan [3][5]. - The highest repurchase price was 34.78 yuan per share, while the lowest was 22.66 yuan per share [3]. Shareholder Transactions - From January 20, 2025, to April 19, 2025, the actual controller of the company, Chen Wenyuan, increased his holdings by 887,093 shares, totaling approximately 26.51 million yuan [3][4]. Share Changes - Before the repurchase, the total number of shares was 442,828,931, which increased to 445,377,843 after the repurchase [4][5]. - The repurchased shares will be used for employee stock ownership plans or equity incentives and will not enjoy rights such as profit distribution or voting rights until utilized [5][6]. Future Plans for Repurchased Shares - The repurchased shares are to be used within three years from the announcement date; otherwise, the board will proceed with capital reduction procedures [5][6].

Group 1 - The company has confirmed that it meets the qualifications to implement the 2025 restricted stock and stock option incentive plan, as there are no disqualifying conditions outlined in relevant laws and regulations [1][2] - The incentive plan's designated recipients do not fall under any disqualifying conditions specified in the regulations, ensuring their eligibility [2] - The company will publicly disclose the names and positions of the incentive plan recipients for at least 10 days before the shareholders' meeting [3] Group 2 - The formulation and review process of the 2025 incentive plan comply with relevant laws and regulations, ensuring no harm to the interests of the company and its shareholders [3] - There are no plans to provide loans, guarantees, or any financial assistance to the incentive recipients [4] - The implementation of the incentive plan is expected to enhance the company's incentive mechanism, attract and retain talent, and align the interests of shareholders, the company, and employees for long-term development [4]

Core Viewpoint - The company has conducted a review of its 2025 restricted stock and stock option incentive plan, confirming its eligibility to implement the plan in accordance with relevant laws and regulations [2][3][4]. Group 1: Eligibility for Implementation - The company does not fall under any disqualifying conditions for implementing the stock incentive plan as outlined in the relevant regulations [2]. - The company has not received any negative or unqualified audit opinions on its financial reports for the last fiscal year [2]. - There have been no instances of improper profit distribution in the last 36 months [2]. Group 2: Qualification of Incentive Objects - The identified incentive objects do not include independent directors, supervisors, foreign employees, or shareholders holding more than 5% of the company's shares [3]. - All selected incentive objects meet the qualifications set forth in the Company Law and other relevant regulations [3]. - The company will publicly disclose the names and positions of the incentive objects for at least 10 days prior to the shareholders' meeting [3]. Group 3: Compliance and Benefits of the Plan - The drafting and review process of the incentive plan complies with all relevant laws and regulations, ensuring no harm to the interests of the company and its shareholders [4]. - The plan does not involve any financial assistance or guarantees to the incentive objects [4]. - The implementation of the incentive plan aims to establish a long-term incentive mechanism, attract and retain talent, and align the interests of shareholders, the company, and employees [4].

Core Viewpoint - The company is proposing a 2025 restricted stock incentive plan aimed at enhancing talent retention and competitiveness in the industry, particularly by including foreign employees as part of the incentive program [2][3][4] Group 1: Eligibility and Compliance - The company has confirmed its eligibility to implement the stock incentive plan, adhering to relevant laws and regulations, including the Company Law and Securities Law [2][4] - The plan excludes individuals who have been deemed inappropriate candidates by the stock exchange or the China Securities Regulatory Commission (CSRC) within the last 12 months [2] - The incentive plan's design and approval process comply with the necessary legal frameworks, ensuring no infringement on the interests of the company and its shareholders [4] Group 2: Incentive Targets - The incentive plan includes key personnel such as Chen Xiaolan, who is a company director and holds over 5% of the company's shares, highlighting her significant role in management [3] - The plan does not include independent directors or other major shareholders, ensuring a focus on operational management rather than ownership interests [3] - The company will publicly disclose the names and positions of the incentive targets at least 10 days prior to the shareholders' meeting [3] Group 3: Plan Approval and Implementation - The implementation of the incentive plan is contingent upon approval from the shareholders' meeting, emphasizing the need for corporate governance [4] - The plan aims to align the interests of management and shareholders, thereby enhancing operational efficiency and supporting sustainable development [4]

Group 1 - The core viewpoint of the article is the legal opinion regarding Shenzhen Kaili Biomedical Technology Co., Ltd.'s 2025 Restricted Stock and Stock Option Incentive Plan, which aims to establish a long-term incentive mechanism to attract and retain talent while aligning the interests of shareholders, the company, and employees [2][4][6] - The incentive plan includes a total of 5.8818 million shares, accounting for approximately 1.36% of the company's total share capital at the time of the announcement [7][10] - The plan consists of two parts: the second category of restricted stock incentive plan and the stock option incentive plan, with specific conditions for granting and vesting [6][10] Group 2 - The company is a publicly listed entity with a registered address in Shenzhen, engaged in the development and production of medical devices and related software [4][8] - The company has been in operation since its initial public offering on April 6, 2017, under the stock code "300633" [4] - The legal opinion confirms that the company meets the necessary conditions for implementing the stock incentive plan and does not fall under any prohibitive circumstances as outlined in relevant regulations [5][10] Group 3 - The vesting conditions for the restricted stock include performance targets based on net profit growth rates over the years 2025 to 2028, with specific percentage increases required for each vesting period [19][23] - The granting price for the restricted stock is set at no less than 15.93 yuan per share, determined based on the average trading price prior to the announcement [17][18] - The plan outlines a comprehensive assessment system at the company, departmental, and individual levels to evaluate performance and determine the vesting of shares [24][26]

证券代码：300633 证券简称：开立医疗 深圳开立生物医疗科技股份有限公司 （草案） 声明 本公司及董事会全体成员保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 本公司所有激励对象承诺，公司因信息披露文件中有虚假记载、误导性陈述 或者重大遗漏，导致不符合授予权益或权益归属/行权安排的，激励对象应当自 相关信息披露文件被确认存在虚假记载、误导性陈述或者重大遗漏后，将由公司 特别提示 一、《深圳开立生物医疗科技股份有限公司 2025 年限制性股票与股票期权 激励计划（草案）》（以下简称"本激励计划"）系依据《中华人民共和国公司 法》《中华人民共和国证券法》《上市公司股权激励管理办法》《深圳证券交易 所创业板股票上市规则》《深圳证券交易所创业板上市公司自律监管指南第 1 号——业务办理》等其他有关法律、法规、规范性文件，以及《深圳开立生物医 疗科技股份有限公司章程》制订。 二、本激励计划采取的激励工具为限制性股票（第二类限制性股票）和股 票期权。股票来源为深圳开立生物医疗科技股份有限公司（以下简称"公司" 或"本公司"）向激励对象定向发行公司 A ...

Core Viewpoint - The article discusses the compliance requirements and conditions for the stock incentive plan of Saiwei Times Technology Co., Ltd, emphasizing the need for adherence to regulations and the importance of transparency in the implementation of such plans [1][3][4]. Compliance Requirements - The financial reports for the most recent accounting year did not receive a negative opinion or inability to express an opinion from registered accountants [3]. - There have been no instances in the last 36 months where profit distribution did not comply with laws, regulations, or company articles [3]. - The stock incentive plan must not exceed 20% of the company's total share capital in terms of the total number of shares involved [4][5]. Incentive Object Requirements - The incentive plan must not include shareholders holding more than 5% of the company's shares unless justified [3]. - No individuals have been identified as inappropriate candidates by the China Securities Regulatory Commission (CSRC) in the last 12 months [3]. - The plan must disclose the names, positions, and number of shares granted to directors and senior management [5][6]. Plan Disclosure Requirements - The stock incentive plan must clearly state its purpose, the basis for selecting incentive objects, and the number of rights to be granted [4][5]. - The plan must include details on the vesting period, grant date, and any conditions for exercising rights [5][6]. - The plan must ensure that the performance assessment indicators are objective, clear, and beneficial for enhancing the company's competitiveness [6][7]. Legal and Procedural Compliance - The company must ensure that the stock incentive plan complies with the "Management Measures for Stock Incentives" and that all procedures for drafting, reviewing, and publicizing the plan are followed [7][8]. - Independent financial advisors must provide complete and compliant professional opinions regarding the plan [11][12].